Compositions and methods for the treatment of Parkinson's disease
US12319929B2 · kind B2 · utility
0Cited by
254References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 15, 2019 |
| Grant date | Jun 3, 2025 |
| Priority date | — |
| Expiry date | Jul 5, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y401/01028
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to methods, formulations and devices for the delivery and therapeutic administration of polynucleotides encoding AADC. The present disclosure relates to methods, formulations and devices for the delivery and therapeutic administration of AAV vectors which include polynucleotides encoding AADC. The present disclosure relates to methods, formulations and devices for the delivery and therapeutic administration of polynucleotides encoding AADC in the treatment of neurological diseases, disorders and conditions, including Parkinson's Disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.